Clinical Trials Using Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564

Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Study of AMV564 in Subjects With Advanced Solid Tumors

    This Phase 1 study is designed to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of AMV564 alone and in combination with Pembrolizumab in patients with advanced solid tumors.
    Location: 3 locations